Clinicopathologic features of collecting duct carcinoma of the kidney-report of 5 case and review ;of literature
10.3969/j.issn.1007-3969.2013.09.007
- VernacularTitle:肾脏集合管癌的临床病理观察
- Author:
Yingjie HUANG
;
Changshui LI
;
Rong GE
;
Chuangfeng LIU
;
Deshang WANG
- Publication Type:Journal Article
- Keywords:
Collecting duct carcinomas of the kidney;
Immunohistochemistry;
Pathologic diagnosis;
Differential diagnosis
- From:
China Oncology
2013;(9):733-736
- CountryChina
- Language:Chinese
-
Abstract:
Background and purpose: Collecting duct carcinomas of the kidney are a rare malignant tumor accounting for<1%of renal malignancies. It is associated with aggressive nature and more than 50%of patients have metastatic disease at the time of initial diagnosis. The diagnosis of collecting duct carcinoma is often dififcult and to some extent is one of exclusion. This study aimed to study the clinicopathologic features of collecting duct carcinoma of the kidney. Methods:We retrieved the data of ifve cases of collecting duct carcinomas of the kidney from pathology ifles, and determined the expressions of CK19, CAM5.2, CK7, Vimentin, CD10, P63 and PaX-8 by pathohistological observation and immunohistochemical examination. Results: The most common symptoms were blood urine, bellyache and abdomen mass. The tumor originated from the medulla of the kidney central zone. Histologically, the tumors demonstrated irregular tubular or papillary architecture with the stroma of inflammatory cells and fibrous tissue proliferation. Immunohistochemically, the tumor cells were positive for CK19(5/5), CAM5.2(5/5), PaX-8(5/5), Vimentin(2/5), CK7(1/5), and negative for P63, CD10. Conclusion: The correct diagnosis in collecting duct carcinomas of the kidney is based on characteristic morphological features and immunophenotype labeling.
